229 filings
Page 5 of 12
8-K
owz7vli yxnwph
27 Sep 16
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
raj5izn cja
20 Sep 16
Departure of Directors or Certain Officers
12:00am
8-K
xlkyonydc3
9 Aug 16
Musclepharm Reports 2016 Second Quarter Financial Results
12:00am
8-K
acac4wddq4l
29 Jun 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
0ix5y 8ot
26 May 16
MusclePharm Corporation Announces More Than $45 Million in Future Commitments Trimmed To Date
12:00am
8-K
mcy4qutg kp5fxxgm
25 May 16
Termination of a Material Definitive Agreement
12:00am
8-K
g7t q5sinba
16 May 16
MusclePharm Announces Closing of Sale of BioZone Laboratories
12:00am
8-K
u92667t gbufdc8
10 May 16
MusclePharm Reports 2016 First Quarter Financial Results
12:00am
8-K
jpmx0t9avzozdq9fbp
27 Apr 16
MusclePharm Enters into Agreement for the Sale of BioZone Laboratories
12:00am
8-K
pkhgv
17 Mar 16
Musclepharm Reports 2015 Fourth-quarter and Full-year Financial Results
12:00am
8-K
vije br5i3g
16 Mar 16
MusclePharm Founder and CEO Steps Down; Board of Directors Appoints Ryan Drexler as Interim CEO and President
12:00am
8-K
9km08mz
1 Mar 16
MusclePharm Announces Selected Preliminary Fourth Quarter 2015 Results
12:00am
8-K
al1qhbd
16 Feb 16
Departure of Directors or Certain Officers
12:00am
8-K
201e4idh k6
12 Feb 16
Other Events
12:00am
8-K
3fzzxjk 9j29m45
14 Jan 16
MusclePharm Completes $10 Million Financing
12:00am
8-K
rxxcb8bem7lacvy1w et
6 Jan 16
Departure of Directors or Certain Officers
12:00am
8-K
5kqwls8likqx0lak28h
10 Dec 15
MusclePharm Executive Chairman Issues Letter to Shareholders on Status of Company
12:00am
8-K
e0l7c
17 Nov 15
MusclePharm to Explore Sale of Its BioZone Laboratories Nevada Subsidiary’s Business
12:00am
8-K
1gvcnj eer
9 Nov 15
MusclePharm Reports 2015 Third Quarter Financial Results
12:00am
8-K
aad2b13e9f154ffnyd7
16 Oct 15
Entry into a Material Definitive Agreement
12:00am